SkylineDx USA, Inc.

SkylineDx is a molecular diagnostics company focused on developing clinically relevant tests that analyze gene expression to support personalized healthcare. They collaborate globally to translate biomarker discoveries into commercial diagnostic assays, with programs targeting oncology, hematology, and infectious diseases. Recognized for innovation, SkylineDx aims to improve patient outcomes through value-based healthcare solutions.